W. Rathmell
Last active: 11/27/2019

W. Rathmell M.D., Ph.D. - Publications

  1. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Liu Y, Sethi NS, Hinoue T, Schneider BG, Cherniack AD, Sanchez-Vega F, Seoane JA, Farshidfar F, Bowlby R, Islam M, Kim J, Chatila W, Akbani R, Kanchi RS, Rabkin CS, Willis JE, Wang KK, McCall SJ, Mishra L, Ojesina AI, Bullman S, Pedamallu CS, Lazar AJ, Sakai R, Cancer Genome Atlas Research Network, Thorsson V, Bass AJ, Laird PW (2018) Cancer Cell 33(4): 721-735.e8
    › Primary publication · 29622466 (PubMed) · PMC5966039 (PubMed Central)
  2. Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma. McDermott DF, Huseni MA, Atkins MB, Motzer RJ, Rini BI, Escudier B, Fong L, Joseph RW, Pal SK, Reeves JA, Sznol M, Hainsworth J, Rathmell WK, Stadler WM, Hutson T, Gore ME, Ravaud A, Bracarda S, Suárez C, Danielli R, Gruenwald V, Choueiri TK, Nickles D, Jhunjhunwala S, Piault-Louis E, Thobhani A, Qiu J, Chen DS, Hegde PS, Schiff C, Fine GD, Powles T (2018) Nat Med 24(6): 749-757
    › Primary publication · 29867230 (PubMed) · PMC6721896 (PubMed Central)
  3. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, Shen R, Taylor AM, Cherniack AD, Thorsson V, Akbani R, Bowlby R, Wong CK, Wiznerowicz M, Sanchez-Vega F, Robertson AG, Schneider BG, Lawrence MS, Noushmehr H, Malta TM, Cancer Genome Atlas Network, Stuart JM, Benz CC, Laird PW (2018) Cell 173(2): 291-304.e6
    › Primary publication · 29625048 (PubMed) · PMC5957518 (PubMed Central)
  4. Balancing dual demands on the physician-scientist workforce. Martin DM, Rathmell WK, Tavazoie SF (2018) J Clin Invest 128(8): 3204-3205
    › Primary publication · 30010627 (PubMed) · PMC6063500 (PubMed Central)
  5. A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily. Korkut A, Zaidi S, Kanchi RS, Rao S, Gough NR, Schultz A, Li X, Lorenzi PL, Berger AC, Robertson G, Kwong LN, Datto M, Roszik J, Ling S, Ravikumar V, Manyam G, Rao A, Shelley S, Liu Y, Ju Z, Hansel D, de Velasco G, Pennathur A, Andersen JB, O'Rourke CJ, Ohshiro K, Jogunoori W, Nguyen BN, Li S, Osmanbeyoglu HU, Ajani JA, Mani SA, Houseman A, Wiznerowicz M, Chen J, Gu S, Ma W, Zhang J, Tong P, Cherniack AD, Deng C, Resar L, Cancer Genome Atlas Research Network, Weinstein JN, Mishra L, Akbani R (2018) Cell Syst 7(4): 422-437.e7
    › Primary publication · 30268436 (PubMed) · PMC6370347 (PubMed Central)
  6. A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples. Chen H, Li C, Peng X, Zhou Z, Weinstein JN, Cancer Genome Atlas Research Network, Liang H (2018) Cell 173(2): 386-399.e12
    › Primary publication · 29625054 (PubMed) · PMC5890960 (PubMed Central)
  7. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV, Omberg L, Wolf DM, Shriver CD, Thorsson V, Cancer Genome Atlas Research Network, Hu H (2018) Cell 173(2): 400-416.e11
    › Primary publication · 29625055 (PubMed) · PMC6066282 (PubMed Central)
  8. A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. Berger AC, Korkut A, Kanchi RS, Hegde AM, Lenoir W, Liu W, Liu Y, Fan H, Shen H, Ravikumar V, Rao A, Schultz A, Li X, Sumazin P, Williams C, Mestdagh P, Gunaratne PH, Yau C, Bowlby R, Robertson AG, Tiezzi DG, Wang C, Cherniack AD, Godwin AK, Kuderer NM, Rader JS, Zuna RE, Sood AK, Lazar AJ, Ojesina AI, Adebamowo C, Adebamowo SN, Baggerly KA, Chen TW, Chiu HS, Lefever S, Liu L, MacKenzie K, Orsulic S, Roszik J, Shelley CS, Song Q, Vellano CP, Wentzensen N, Cancer Genome Atlas Research Network, Weinstein JN, Mills GB, Levine DA, Akbani R (2018) Cancer Cell 33(4): 690-705.e9
    › Primary publication · 29622464 (PubMed) · PMC5959730 (PubMed Central)
  9. Untangling ccRCC prognosis with SLINKY. Reinfeld BI, Rathmell WK (2017) Oncotarget 8(12): 18620-18621
    › Primary publication · 28220033 (PubMed) · PMC5386631 (PubMed Central)
  10. Strategies to overcome therapeutic resistance in renal cell carcinoma. Siska PJ, Beckermann KE, Rathmell WK, Haake SM (2017) Urol Oncol 35(3): 102-110
    › Primary publication · 28089416 (PubMed) · PMC5318278 (PubMed Central)